WHO ICTRP trial
A Phase ? Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of…
ChiCTR2500099933 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500099933 |
|---|---|
| Public title | A Phase ? Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Different Dosing Regimens of SYS6010 in Patients with Advanced Solid Tumors |
| Scientific title | A Phase ? Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Different Dosing Regimens of SYS6010 in Patients with Advanced Solid Tumors |
| Primary sponsor | Fujian Provincial Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1-2 |
| Countries | China |
| Conditions | Advanced Solid Tumors |
| Interventions | Dose Escalation Phase: SYS6010:SYS6010;Dose Expansion Phase:SYS6010:SYS6010 |
| Registration date | Apr 1, 2025 |
| Target size | Dose Escalation Phase: SYS6010:39;Dose Expansion Phase:SYS6010:160 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: